GLP1R and atherosclerosis: Another GLP-1 receptor agonist, exendin-4, was reported to reduce the accumulation of monocytes/macrophages in the arterial wall of ApoE−/− mice partly through activation of the cAMP/PKA pathway, which may contribute to attenuation of atherosclerosis (Arakawa et al., 2010).